COEPW icon

Coeptis Therapeutics Holdings, Inc. Warrants

0.0323 USD
+0.0000
0.00%
At close May 19, 4:00 PM EDT
1 day
0.00%
5 days
8.03%
1 month
280.00%
3 months
31.30%
6 months
61.50%
Year to date
-9.78%
1 year
-16.10%
5 years
-94.62%
10 years
-94.62%
 

About: Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Employees: 7

0
Funds holding %
of 7,202 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0% more funds holding

Funds holding: 12 [Q4 2024] → 12 (+0) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.44% less ownership

Funds ownership: 2.36% [Q4 2024] → 1.92% (-0.44%) [Q1 2025]

57% less capital invested

Capital invested by funds: $20.4K [Q4 2024] → $8.72K (-$11.6K) [Q1 2025]

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Research analyst outlook

We haven’t received any recent analyst ratings for COEPW.

Financial journalist opinion

We haven’t received any recent news articles for COEPW.

Charts implemented using Lightweight Charts™